Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alon D Altman

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|December 26, 2017
Examining the Selection Criteria of Neoadjuvant Chemotherapy PatientsJulia Mayba, Pascal Lambert, Donna Turner, et al.
CMAJ Open|April 13, 2017
Diagnostic and referral intervals for Manitoba women with epithelial ovarian cancer - the Manitoba Ovarian Cancer Outcomes (MOCO) study group: a retrospective cross-sectional studyAllison J Love, Pascal Lambert, Donna Turner, et al.
Gynecologic Oncology|March 14, 2021
Chromosome instability is prevalent and dynamic in high-grade serous ovarian cancer patient samplesClaire R Morden, Ally C Farrell, Mirka Sliwowski, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 14, 2017
Examining the Effects of Time to Diagnosis, Income, Symptoms, and Incidental Detection on Overall Survival in Epithelial Ovarian Cancer: Manitoba Ovarian Cancer Outcomes (MOCO) Study GroupAlon D Altman, Pascal Lambert, Allison J Love, et al.
Plos Genetics|April 5, 2017
The temporal dynamics of chromosome instability in ovarian cancer cell lines and primary patient samplesSigne Penner-Goeke, Zelda Lichtensztejn, Megan Neufeld, et al.
American Journal of Surgery|January 1, 2019
Extended thromboprophylaxis with low-molecular weight heparin (LMWH) following abdominopelvic cancer surgeryMarc Carrier, Alon D Altman, Normand Blais, et al.
Obstetrics and Gynecology|April 8, 2016
Hormone Use After Nonserous Epithelial Ovarian Cancer: Overall and Disease-Free SurvivalLaura Power, Georgia Lefas, Pascal Lambert, et al.
Current Oncology (Toronto, Ont.)|December 22, 2022
Referral, Genetic Counselling, and <i>BRCA</i> Testing in the Manitoba High-Grade Serous Ovarian Cancer Population, 2004-2019Kelcey Winchar, Pascal Lambert, Kirk J McManus, et al.
BMJ Supportive & Palliative Care|December 23, 2024
Anaemia, blood transfusions and survival in high-grade endometrial cancer: retrospective studyHannah H Foggin, Pascal Lambert, Lung Fung Tsang, et al.
Journal of Genetic Counseling|February 22, 2023
Exploring the role of a multidisciplinary hereditary gynecologic oncology clinic in epithelial ovarian cancer risk-reducing surgical decision-making practices: A mixed-methods studySelina Casalino, Sharon Bruce, Kim Serfas, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|December 26, 2017
Examining the Selection Criteria of Neoadjuvant Chemotherapy PatientsJulia Mayba, Pascal Lambert, Donna Turner, et al.
CMAJ Open|April 13, 2017
Diagnostic and referral intervals for Manitoba women with epithelial ovarian cancer - the Manitoba Ovarian Cancer Outcomes (MOCO) study group: a retrospective cross-sectional studyAllison J Love, Pascal Lambert, Donna Turner, et al.
Gynecologic Oncology|March 14, 2021
Chromosome instability is prevalent and dynamic in high-grade serous ovarian cancer patient samplesClaire R Morden, Ally C Farrell, Mirka Sliwowski, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 14, 2017
Examining the Effects of Time to Diagnosis, Income, Symptoms, and Incidental Detection on Overall Survival in Epithelial Ovarian Cancer: Manitoba Ovarian Cancer Outcomes (MOCO) Study GroupAlon D Altman, Pascal Lambert, Allison J Love, et al.
Plos Genetics|April 5, 2017
The temporal dynamics of chromosome instability in ovarian cancer cell lines and primary patient samplesSigne Penner-Goeke, Zelda Lichtensztejn, Megan Neufeld, et al.
American Journal of Surgery|January 1, 2019
Extended thromboprophylaxis with low-molecular weight heparin (LMWH) following abdominopelvic cancer surgeryMarc Carrier, Alon D Altman, Normand Blais, et al.
Obstetrics and Gynecology|April 8, 2016
Hormone Use After Nonserous Epithelial Ovarian Cancer: Overall and Disease-Free SurvivalLaura Power, Georgia Lefas, Pascal Lambert, et al.
Current Oncology (Toronto, Ont.)|December 22, 2022
Referral, Genetic Counselling, and <i>BRCA</i> Testing in the Manitoba High-Grade Serous Ovarian Cancer Population, 2004-2019Kelcey Winchar, Pascal Lambert, Kirk J McManus, et al.
BMJ Supportive & Palliative Care|December 23, 2024
Anaemia, blood transfusions and survival in high-grade endometrial cancer: retrospective studyHannah H Foggin, Pascal Lambert, Lung Fung Tsang, et al.
Journal of Genetic Counseling|February 22, 2023
Exploring the role of a multidisciplinary hereditary gynecologic oncology clinic in epithelial ovarian cancer risk-reducing surgical decision-making practices: A mixed-methods studySelina Casalino, Sharon Bruce, Kim Serfas, et al.
Pageof 7